EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study

Anastasia V Blokhina iD, Alexandra I Ershova, Anna V Kiseleva iD, Evgeniia A Sotnikova, Marija Zaicenoka iD, Anastasia A Zharikova iD, Yuri V Vyatkin, Vasily E Ramensky iD, Elizaveta A Novokhatskaya iD, Anna L Borisova, Svetlana A Shalnova, Alexey N Meshkov iD und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157376 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anastasia V Blokhina und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3…. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type III, Apolipoproteins E. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial dysbetalipoproteinemia (FD) is a prevalent and highly atherogenic hyperlipoproteinemia associated with the ε2/ε2 APOE genotype or rare APOE variants. The contributions of additional genetic and clinical factors to the FD phenotype remain unclear. We investigated these factors in both autosomal recessive and autosomal dominant forms of FD. Targeted (n = 4666) and exome (n = 194) sequencing were used to identify the ε2/ε2 APOE genotype or rare FD-causative APOE variants. Twenty-four lipid-related genes and forty variants included in a polygenic risk score for hypertriglyceridemia (HTG) were analyzed. FD was defined by the presence of FD variants and triglycerides (TG) ≥ 1.5 mmol/L (main study group). The comparison group consisted of patients with FD variants but TG < 1.5 mmol/L. Univariable and multivariable regression analyses were performed. A total of 71 unrelated subjects were identified (45.1% male, median age 50 years). FD was diagnosed in 52 patients, while 19 had FD variants only. Age (p = 0.019), elevated polygenic risk for HTG (p = 0.001), and the presence of metabolic syndrome components (p = 0.014) were independently associated with the FD phenotype. TG levels were significantly associated with polygenic burden (0.05 mmol/L per percentile), the presence of additional rare lipid-related variants (7.0 mmol/L), and glucose metabolism disorders (3.62 mmol/L), together explaining 30% of TG variance in cross-validated model. These results highlight the interplay of genetic and metabolic factors in FD development and support the integration of HTG genetic risk scores and metabolic control into personalized FD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIIApolipoproteins EHumansMaleFemaleMiddle AgedCross-Sectional StudiesPhenotypeAdultTriglyceridesGenotypeHypertriglyceridemiaMultifactorial InheritanceAgedGenetic Predisposition to DiseaseMetabolic Syndrome

Stichwörter der Autor:innen

APOEadditive riskcardiometabolic indexfamilial dysbetalipoproteinemiahyperlipoproteinemia type IIImetabolic factorspolygenic hypertriglyceridemiapolygenic risk scoreremnant lipoproteinε2/ε2

Substanzen

TriglyceridesApolipoproteins E

Autor:innen und Institutionen

  • National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
  • Moscow Center for Advanced Studies, 20 Kulakova Str., 123592 Moscow, Russia.
  • Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
  • Department of Natural Sciences, Novosibirsk State University, 1, Pirogova Str., 630090 Novosibirsk, Russia.
  • Institute for Artificial Intelligence, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
  • National Medical Research Center for Cardiology, 3-ya Cherepkovskaya Str., 15A, 121552 Moscow, Russia.

ORCID-Profile: Anastasia V Blokhina, Anna V Kiseleva, Marija Zaicenoka, Anastasia A Zharikova, Vasily E Ramensky, Elizaveta A Novokhatskaya, Alexey N Meshkov, Oxana M Drapkina

Zitieren

APA

Blokhina, A. V., Ershova, A. I., Kiseleva, A. V., Sotnikova, E. A., Zaicenoka, M., Zharikova, A. A., Vyatkin, Y. V., Ramensky, V. E., Novokhatskaya, E. A., Borisova, A. L., Shalnova, S. A., Meshkov, A. N., & Drapkina, O. M. (2025). Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157376

Vancouver

Blokhina AV, Ershova AI, Kiseleva AV, Sotnikova EA, Zaicenoka M, Zharikova AA, et al. Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157376

BibTeX
@article{Blokhina2025,
  author = {Blokhina, Anastasia V and Ershova, Alexandra I and Kiseleva, Anna V and Sotnikova, Evgeniia A and Zaicenoka, Marija and Zharikova, Anastasia A and Vyatkin, Yuri V and Ramensky, Vasily E and Novokhatskaya, Elizaveta A and Borisova, Anna L and Shalnova, Svetlana A and Meshkov, Alexey N and Drapkina, Oxana M},
  title = {Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157376}
}
Kostenlos starten →